Tacalcitol
As of the edition of 20 October 2026, Tacalcitol is a small molecule: marketed, first approved in 1995 (CH).
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 1995
- Kind
- Small molecule
- Brand name
- Curatoderm
- First approved
- 29 August 1995 (CH)
- Approvals on record
- 2 in 1 region
- Holder of the most recent approval
- Almirall
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Who has held its approvals
| Company | Role | Years |
|---|---|---|
| Almirall | Applicant | 1995 to now |